Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells
- PMID: 20804749
- DOI: 10.1016/j.yexcr.2010.08.008
Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells
Abstract
Mesenchymal stromal cells (MSCs) have important immunosuppressive properties, but the mechanisms and soluble factors involved in these effects remain unclear. We have studied prostaglandin-E2 (PGE2) as a possible candidate implied in adipose tissue-derived MSCs (Ad-MSCs) immunosuppressive properties over dendritic cells and T lymphocytes, compared to bone marrow derived MSCs (BM-MSCs). We found that both MSCs inhibited the maturation of myeloid-DCs and plasmocytoid-DCs. High levels of PGE2 were detected in DCs/MSCs co-cultures. Its blockade with indomethacin (IDM) allowed plasmocytoid-DCs but not myeloid-DCs maturation. Additionally, high levels of PGE2 were found in co-cultures in which Ad-MSCs or BM-MSCs inhibited activated T cells proliferation and pro-inflammatory cytokines production. PGE2 blockade by IDM preserved T lymphocytes proliferation but did not restore the pro-inflammatory cytokines secretion. However, an increased expression of transcription factors and cytokines genes involved in the Th1/Th2 differentiation pathway was detected in the T cells co-cultured with Ad-MSCs, but not with BM-MSCs. In conclusion, we propose that PGE2 is a soluble factor mediating most of the immunosuppressive effects of Ad-MSCs and BM-MSCs over p-DCs maturation and activated T lymphocytes proliferation and cytokine secretion.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells.Biochem Biophys Res Commun. 2012 Mar 9;419(2):215-20. doi: 10.1016/j.bbrc.2012.01.150. Epub 2012 Feb 7. Biochem Biophys Res Commun. 2012. PMID: 22333568
-
Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells.Immunol Lett. 2009 Sep 22;126(1-2):37-42. doi: 10.1016/j.imlet.2009.07.010. Epub 2009 Jul 30. Immunol Lett. 2009. PMID: 19647021
-
Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.Stem Cells. 2006 Nov;24(11):2582-91. doi: 10.1634/stemcells.2006-0228. Epub 2006 Jul 27. Stem Cells. 2006. PMID: 16873762
-
Immune plasticity of bone marrow-derived mesenchymal stromal cells.Handb Exp Pharmacol. 2007;(180):45-66. doi: 10.1007/978-3-540-68976-8_3. Handb Exp Pharmacol. 2007. PMID: 17554504 Review.
-
New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins.Scand J Immunol. 2011 Feb;73(2):79-84. doi: 10.1111/j.1365-3083.2010.02491.x. Scand J Immunol. 2011. PMID: 21198747 Review.
Cited by
-
Review: Research progress of adipose-derived stem cells in the treatment of chronic wounds.Front Chem. 2023 Feb 13;11:1094693. doi: 10.3389/fchem.2023.1094693. eCollection 2023. Front Chem. 2023. PMID: 36860643 Free PMC article. Review.
-
Advancements in Regenerative Strategies Through the Continuum of Burn Care.Front Pharmacol. 2018 Jul 9;9:672. doi: 10.3389/fphar.2018.00672. eCollection 2018. Front Pharmacol. 2018. PMID: 30038569 Free PMC article. Review.
-
Multiple Injections of Adipose-Derived Stem Cells Improve Graft Survival in Human-to-Rat Skin Xenotransplantation through Immune Modulation.Tissue Eng Regen Med. 2023 Oct;20(6):905-919. doi: 10.1007/s13770-023-00552-x. Epub 2023 Aug 2. Tissue Eng Regen Med. 2023. PMID: 37531072 Free PMC article.
-
Human adipose-derived stromal/stem cells induce functional CD4+CD25+FoxP3+CD127- regulatory T cells under low oxygen culture conditions.Stem Cells Dev. 2014 May 1;23(9):968-77. doi: 10.1089/scd.2013.0152. Epub 2014 Mar 11. Stem Cells Dev. 2014. PMID: 24405386 Free PMC article. Clinical Trial.
-
"Adipose-derived mesenchymal stem cell therapy for the management of female sexual dysfunction: Literature reviews and study design of a clinical trial".Front Cell Dev Biol. 2022 Sep 28;10:956274. doi: 10.3389/fcell.2022.956274. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36247008 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources